SCHEMBL19792009

SCHEMBL19792009

CCCC(CC)C(CC)CF

nearest known ligand 0.39

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
METAP1 P53582 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1404786 0.84 LMNA (0.48) LMNAMETAP1
SCHEMBL16214986 0.83 OPRM1 (0.36) LMNA
SCHEMBL19072756 0.81 LMNA (0.46) LMNAMETAP1
SCHEMBL16718867 0.81 LMNA (0.46) LMNAMETAP1
SCHEMBL13825276 0.80 METAP1 (0.33) METAP1
SCHEMBL26332004 0.74 LMNA (0.46) LMNAMETAP1
SCHEMBL22964803 0.74
SCHEMBL5496711 0.73 ALDH1A1 (0.42) LMNA
SCHEMBL598055 0.73 LMNA (0.40) LMNAMETAP1
SCHEMBL7861657 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3272749-A1 AMINO-SUBSTITUTED IMIDAZO[1,2-A]PYRIDINECARBOXAMIDES AND THEIR USE AS STIMULATORS OF SOLUBLE GUANYLATE CYCLASE Bayer Pharma Aktiengesellschaft (DE) 2018-01-24 EP disclosed